New pill tested for Life-Threatening transplant complication
NCT ID NCT04941404
Summary
This study tested a new oral medication called TQ05105 for patients with a severe complication of stem cell transplants called acute graft-versus-host disease (aGVHD) that does not respond to standard steroid treatment. The main goals were to check the drug's safety, how well the body processes it, and to see if it could help control the disease. It involved a small group of 13 patients aged 12 to 75.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOCORTICOID-REFRACTORY AGVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hematology Hospital of the chinese Academy of Medical Sciences
Tianjing, Tianjing, 300020, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215008, China
-
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310012, China
Conditions
Explore the condition pages connected to this study.